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Purpose of review
The association between endocrine and neuropsychiatric disorders was established
long ago, with solid evidence. According to a multidimensional model of mental
disorders, one can conceptualize sex and gender-related endocrinological dysfunctions
as a cluster of risk factors included in the biological determinants of those disorders.
Recent findings
Gender and sexual dimorphism in brain functions and pathways may have a main impact
and synergistic effects on health differences in both men and women. To explain these
differences, hormonal reactivity to stress, sex hormones and gene–environment
interactions are among the most researched mechanisms.
Summary
In this paper, we review updated data on sex and gender differences in stress reactivity,
concerning the hypothalamic–pituitary–adrenal axis, endocrinological dysfunction and
vulnerability to major psychiatric disorders, in a stress-diathesis approach. Mainly
schizophrenia and affective disorders are discussed, according to recent investigation,
in terms of early determinants of stress reactivity, the interplay of genetic expression and
gender role, their responsibility in biological modulation and their hypothetical
contribution to explain gender differences in prevalence and clinical aspects of mental
disorders.
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0951-7367Introduction
The association between endocrine and neuropsychiatric
disorders was established long ago, with solid evidence.
In a multidimensional model of mental disorders, one can
conceptualize sex and gender-related endocrinological
dysfunctions as a cluster of risk factors included in the
biological determinants of those disorders [1–3].
With regard to mental health, sex and gender are related
but distinct concepts that include a number of risk factors
of a different nature. Recent research tends to emphasize
the interaction between those risk factors and their
impact on the development of mental disorders [4,5].Neuroendocrinological dysfunction and
mental disorders
Different hormonal profiles and biological events, in each
sex, can explain some of the differences in presentation of
mental disorders and gender-related resilience or vulner-
ability. Stress reactivity is one of the most important
aspects of vulnerability and it can be understood accord-0951-7367  2010 Wolters Kluwer Health | Lippincott Williams & Wilkinsing to its biological nature but also according to specific
aspects in development and maintenance of gender roles
[6,7,8,9].Stress and the hypothalamic–pituitary–
adrenal axis
The response of the hypothalamic–pituitary–adrenal
(HPA) axis to stressful stimuli is essential to maintain
physiological stability in the human body.
Physiological reactivity in response to acute stressors is
different in males and females. Kajantie and Phillips [10]
reviewed sex differences in the response of the HPA axis
and the autonomic nervous system to acute psychosocial
stress and they concluded that, despite some differences
determined by the stressor itself, there are important
differences in both sexes with a clear effect of hormonal
status according to menstrual cycle, menopause or preg-
nancy. Adult women between puberty and menopause
have a reduced HPA and autonomic reactivity compared
with men within the same age group. Before puberty
and after menopause, sex differences are small orDOI:10.1097/YCO.0b013e3283399b86
370 Medical comorbiditynonexistent, but, in pregnancy, the stress responses are
attenuated, perhaps, according to the authors, as a result
of evolutionary pressure, to protect the fetus from the
negative effects of maternal stress reactivity [10]. Accord-
ing to different authors, investigation showed that
corticosteroid-binding globulin, estrogens and arginine
vasopressin (AVP) seem involved in HPA axis regulation
and exhibit different patterns in both sexes, in animal
models of stress reactivity and in humans [11,12].
Concerning the nature of stimuli, Uhart et al. [6] demon-
strated that, in response to different stressors, men showed
a stronger HPA axis response to psychological stressors and
women showed greater hormonal reactivity in response to
pharmacological stimulation with naloxone.
It is well documented that fetal exposure to sex steroids
is responsible for sexual dimorphism, in both brain struc-
ture and function. There is growing evidence that
maternal stress increases corticosteroid levels in the fetal
brain, decreases testosterone levels in men and alters
brain catecholamine activity in women [13].
The relationship between stress and sex, in animal
models of stress pathway dysregulation, related to the
experience of prenatal stress or early-life stressful events,
highlights periods of developmental vulnerability result-
ing in sex differences for stress sensitivity or neuropsy-
chiatry disease vulnerability. In fact, studies in humans
and rodents showed evidence that increased stress
responsiveness or inability to respond to stress and main-
tain homeostatic balance can induce negative brain
effects [14]. The impact of the stress insult is depen-
dent on the developmental timing, which becomes
evident for neurodevelopmental disorders such as schizo-
phrenia. A recent investigation [15] revealed an associ-
ation between maternal stress during the first trimester
and an increased risk of schizophrenia in males.
Goel and Bale [14] proposed that stress system dysre-
gulation and consequent disease vulnerability might be
explained through epigenetic changes related to hormo-
nal modulation of stress circuits as well as gene expres-
sion at critical developmental points.
Several investigations reviewed by Heim et al. [16,17]
showed that, in humans, childhood trauma is associated
with sensitization of the neuroendocrine stress response,
glucocorticoid resistance, increased central corticotropin-
releasing factor activity, immune activation and reduced
hippocampal volume. For these authors, the risk of
developing depression in response to stress may be
secondary to neuroendocrine changes associated with
early-life stress, eventually due to the failure of a con-
nected neural circuitry involved in emotional, neuro-
endocrine and autonomic control, as well as other riskfactors, such as female sex and genetic dispositions,
further increasing vulnerability for depression. In several
psychiatric and medical disorders, frequently related to
depression and aggravated by stress, similar associations
are described [16,17].
According to recent research, the role of a functional
polymorphism in the promoter region of the serotonin
transporter gene (5HTTLPR) is controversial, with incon-
sistent results, but corticotrophin-releasing hormone
receptor 1 (CRHR1) gene and sex interact in moderating
effects of childhood trauma on adult depression [17].Mental disorders: sex and gender matters
Gender differences in prevalence, clinical manifestations
and evolution in mental disorders are well known.
Depression, anxiety and affective disorders, schizo-
phrenia, substance abuse or eating disorders have dis-
tinctive patterns in men and women, probably because of
genetic and biological determinants but also because of
psychosocial and cultural factors [2,18,19].
Reported gender-based differences in mental health may
arise from several levels: biomedical (genetic, hormonal,
anatomical and physiological), psychosocial (personality,
coping and symptom reporting), epidemiological (popu-
lation-based risk factors) or from a more global viewpoint
[2]. Psychosocial stressors, the burden of stressful life-
events, stress reactivity, coping strategies and their
impact on health are different in men and women [10,20].
In order to clarify the relationship of gender and sexual
orientation with treatment received for substance use or
mental disorders, Grella et al. [21] conducted a population-
based survey, applying a behavioral model for vulnerable
populations to 2074 participants aged 18–64 years, in
California. They concluded that sexual orientation and
gender had the main effect on receiving treatment in the
last year, after controlling for the presence of mental
disorders and other predisposing factors [21].Affective disorders
Differences in the rates of affective disorders between
women and men may be related to gender differences in
gonadal steroid levels that regulate brain monoamines
implicated in mood regulation (serotonin, norepi-
nephrine, dopamine, acetylcholine, g-aminobutyric acid
and glutamate). The association of a higher risk for
affective instability in premenstrual or perimenopausal
women has been attributed to fluctuations in 17-b-estra-
diol. Even if the effects of estrogens on mood appear to
be complex and not fully understood, the hypothesis for
an increased risk for depression during some reproductive
stages has been explained by the cycling levels of gonadal
Gender, endocrine dysfunction, mental disorder Figueira and Ouakinin 371steroids on neurotransmitter systems possibly interacting
with genetic vulnerability and life stress [22]. One of
the challenging issues concerns the identification of the
complex underlying neuronal mechanisms responsible
for hormone–stress interaction [23]. Animal research
has indicated that both gender and reproductive steroids
regulate basal HPA axis and stimulate its function. In
women, the regulatory effects of changes in reproductive
steroids or menstrual cycle phase in the HPA axis are less
well studied and understood. The findings of a luteal
phase increase in HPA axis activity are contradictory,
with several kinds of stressors; although some studies
identified increased stimulated cortisol, others failed to
find a luteal phase increase in HPA axis activity [24].
Women with premenstrual dysphoric disorder (PMS), a
combination of both affective symptoms with low stress
adaptation during the luteal phase, are a growing field for
research in determining the pathophysiological role of
reproductive steroids in HPA axis regulation. Studies of
HPA axis abnormalities characteristic of major depression
conducted with PMS patients are inconclusive to date.
Evidence from animal studies suggests that females are
relatively resistant to the neurobiological effects of acute
and chronic stress as opposed to males, who seem to have
a greater HPA axis response to stress, despite the sex
differences for the prevalence of affective and anxiety
disorders [1]. Other risk factors such as childhood trauma
associated with genetic disposition can interfere with
components of stress response and increase vulnerability
for depression in women [16]. There is a need for further
research clarifying the role of reproductive hormones for
stress-related biological changes and emotional behavior
in order to understand the nature of gender-related
affective disorders.Schizophrenia
Research on causal aspects of schizophrenia has been
focused at predisposing genes and environmental risk
factors. In humans as well as in animal models, schizo-
phrenia has been linked with maternal gestational stress
and it is generally accepted that human vulnerability may
be higher during the first trimester of gestation. Hormo-
nal responses following acute psychological stress,
namely the HPA axis and sex hormone regulation, their
impact on brain development and epigenetic program-
ming during early prenatal stress, are important pathways
to explain these facts [15,25,26].
Malaspina et al. [25] tried to clarify the role of an acute
maternal stress, investigating, in a cohort prospective
study, the offspring of women who were pregnant at a
time of war. Data from their cohort of 88 829 infants
displayed a raised incidence of schizophrenia for those in
the second month of fetal life, higher in females than in
males, suggesting both sex specificity and a relativelynarrow window of vulnerability, even after controlling for
potential confounders [25].
Discussing the importance of the interaction between
genetic and environmental factors, Oh and Petronis [27]
stated that ‘The epigenetic model of schizophrenia can
be thought of as a result of a chain of deviant epigenetic
events, which begins with a preepimutation (an epige-
netic change that takes place during gametogenesis or
embryogenesis). A preepimutation increases the risk for
schizophrenia, but it is not sufficient to cause the disease.
The phenotypic outcome, that is, presence or absence of
the disease, is dependent on the overall effect of a series
of prenatal and postnatal factors on the preepimutation.
The epigenetic pattern is altered over time by the
external environmental factors, stochastic events and
hormones, further increasing or decreasing the degree
of the epigenetic misregulation’ [27].
With regard to cognitive functions and disease evolution,
the literature addressing sex differences in schizophrenia
generally reports male patients as being more impaired
than female patients. Bozikas et al. [28] investigated 96
patients with schizophrenia and gender-matched healthy
controls to observe whether differences in cognitive
performance in healthy men and women are preserved
in patients with schizophrenia. Using a battery of neu-
ropsychological tests to assess attention, working mem-
ory, abstraction, inhibition, fluency, verbal learning,
memory, visuospatial skills and psychomotor speed, it
was concluded that the degree of cognitive impairment
was the same for male and female patients with schizo-
phrenia and sex differences found among the patients
were similar to those found in healthy controls. There-
fore, the authors considered that differential decrements
in basic cognition were not accountable for the favorable
course of schizophrenia in women compared with men
[28].
Several investigations support the fact that there are
gender differences in age of onset, severity of symptoms
and long-term functioning in schizophrenia, with differ-
ent patterns of prodromal symptoms beginning before
the disorder onset [29,30]. As Lewine [31] has already
indicated, several aspects of schizophrenia, such as the
onset, may be best pursued from a biological (sex differ-
ence) perspective, whereas a sociocultural perspective,
including gender differences, may be better to under-
stand different aspects, such as neuropsychological func-
tioning.Conclusion
Gender and sexual dimorphism in brain functions and
pathways may have the main impact and synergistic
effects on health differences in men and women.
372 Medical comorbidityResearch in sex-linked biological determinants for psy-
chiatric disorders has progressed during recent years
yielding new insights in etiopathogenic mechanisms.
Nevertheless, gender-related determinants appear to
have been less clarified mainly because of methodologi-
cal issues. Interactions between biological, psychological
and sociocultural factors are complex and current para-
digms have, as yet, insufficient explanatory power.References and recommended reading
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